Form 8-K - Current report:
SEC Accession No. 0001641172-25-004976
Filing Date
2025-04-16
Accepted
2025-04-16 09:00:09
Documents
16
Period of Report
2025-04-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47323
2 ex3-1.htm EX-3.1 14475
3 ex99-1.htm EX-99.1 16287
4 ex99-1_001.jpg GRAPHIC 19204
  Complete submission text file 0001641172-25-004976.txt   289996

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bmra-20250415.xsd EX-101.SCH 3018
6 XBRL LABEL FILE bmra-20250415_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE bmra-20250415_pre.xml EX-101.PRE 24167
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3670
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 25841338
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)